CXCL12 and CXCR4 in the Peripheral Blood of Patients with Parkinson’s Disease

Vahid Bagheri, Hossein Khorramdelazad, Gholamhossein Hassanshahi, Amir Moghadam Ahmadi, Alireza Vakilian

NeuroImmunoModulation · 2018 · 46 citations · 20 references

Abstract

Our findings provide new information on the expression of CXCL12/CXCR4 in PD. CXCR4 expression in PBMC or CXCL12 serum levels may be potential biomarkers of inflammation in PD patients.

References

20